AVXL

Conviction 49HealthcareScan · Mon, Aug 10, 2026

AVXL$3.39+1.35%

ResistanceSupportVol 14

Vol MA14 1.15M

May 11May 28Jun 16Jul 6Jul 23Aug 10

ANAVEX LIFE SCIENCES CORP.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.anavex.com ↗

Price3.39

Change+1.35%

Gap-0.30%

Rel volume1.56×

Avg volume1.1M

Avg $ vol3.05M

SMA 202.72

SMA 502.66

SMA 2003.88

Price vs 50+27.10%

Price vs 200-12.73%

MA stackmixed

50/200 cross—

Supertrendup · 2.87

RSI (14)74

MACD hist0.10

MACD cross—

Stoch %K / %D95 / 95

ADX (14)27

+DI / −DI37 / 10

RSI divergence—

MACD divergence—

ATR %+4.81%

ADR %5.58%

52w high11.35

52w low2.34

From 52w high-70.18%

Above 52w low+44.66%

New 52w highNo

SqueezeOff

Bollinger width51.23%

%B0.98

Donchian pos95.76%

Donchian high3.44

Donchian low2.26

AVWAP (52w high)4.66

vs AVWAP high-27.40%

AVWAP (52w low)2.79

vs AVWAP low+21.27%

OBV trendUp

Chaikin MF (20)0.22

Today vs 20d1.56×

Avg vol (14d)1.15M

Avg vol (20d)1.1M

Avg $ vol (20d)3.05M

Market cap313.69M

RS 3m (vs SPY)+1.35%

RS 6m (vs SPY)-26.45%

RS line new highNo

Trend template3/8

Technical rank47.7

1 week+14.75%

1 month+35.40%

3 months+5.12%

6 months-17.44%

1 year-69.82%

YTD-8.02%

P/E-6.76

P/B2.48

P/S—

P/FCF-8.03

EPS-0.5400

Div yield—

ROE-36.63%

ROA-34.87%

Debt/Eq0.00

Current3.33

EV/EBITDA-3.54

Gross margin—

Net margin—

Rev growth—

EPS growth-7.85%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value181.95M

Revenue—

Net income-5.68M

Gross profit—

Free cash flow-39.05M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out92.67M

Employees34

ListedWed, Aug 2, 2006

Free float87.81M

Float %94.8%

Short interest14.14M

Days to cover15.6d

Short volume53.7%

Squeeze score75 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank47.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.79

Support2.32

Days since event—

Candle confirm—

News sentiment—

Financials as of Wed, Dec 31, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVXL

All disclosures →

No recent disclosed trades by Congress in AVXL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVXL

No recent insider (Form 4) filings in AVXL. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in AVXL · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.